Stay updated on Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF
Sign up to get notified when there's something new on the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page.

Latest updates to the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page
- Check4 days agoChange DetectedLocations section was updated to include many new study sites across multiple regions (US states, Canada, UK, Australia, and other areas). The HHS Vulnerability Disclosure item was removed.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange Detected- Revision: v3.3.2 updated in the page footer, replacing v3.3.1. - This is a minor maintenance update and does not affect study content or results - To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded a PubMed auto-fill note indicating publications may not be about the study; updated the page revision to v3.3.1 and removed the older PubMed attribution text tied to v3.2.0.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded a study location: Tainan, Taiwan, 704, and removed the alternate listing 'Tainan City, Taiwan, 704' to standardize site names. The government funding status notice banner was also removed from the page.SummaryDifference0.2%

- Check55 days agoChange DetectedThe two screenshots of the Gemini 2 study page appear identical in content and structure, with no meaningful differences in study details or layout.SummaryDifference0.2%

- Check83 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference0.7%

Stay in the know with updates to Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF
Enter your email address, and we'll notify you when there's something new on the Gemini 2 Clinical Trial: DTG/3TC vs. DTG/FTC/TDF page.